Figure 6.
WRAP53 overexpression correlates with poor prognosis in head and neck cancer. (a) WB analysis of WRAP53 and β-actin protein levels in HNSCC cells. (b) Densitometric quantifications of WRAP53 protein levels in the HNSCC cells shown in (a). Levels of WRAP53 have been normalized against β-actin levels. (c) WB analysis of EGFR, Survivin, p53 and β-actin protein levels in the same set of HNSCC cells as in (a). (d) Immunohistochemical staining of WRAP53 in primary HNSCC tumors